Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 06, 2023

SELL
$1.1 - $2.86 $1,100 - $2,860
-1,000 Reduced 5.85%
16,086 $27,000
Q2 2022

Jul 08, 2022

BUY
$2.0 - $4.78 $34,172 - $81,671
17,086 New
17,086 $37,000
Q1 2022

Apr 18, 2022

SELL
$3.34 - $6.05 $59,572 - $107,907
-17,836 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$5.46 - $9.69 $97,384 - $172,830
17,836 New
17,836 $108,000

Others Institutions Holding MYMD

About MyMD Pharmaceuticals, Inc.


  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track This Portfolio

Track Taylor & Morgan Wealth Management, LLC Portfolio

Follow Taylor & Morgan Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor & Morgan Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taylor & Morgan Wealth Management, LLC with notifications on news.